Bone Growth Stimulators Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	138 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224230

Best Price Guarantee
Price	from $4,850
Length	138 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224230

Bone Growth Stimulators Market

Growth Factors of Bone Growth Stimulators Market

The bone growth stimulators market size was reached at a value of USD 2.01 billion in 2023, and the market is now projected to grow from USD 2.10 billion in 2024 to USD 3.11 billion by 2032, exhibiting a CAGR of 5.0% during the forecast period of 2023-2032.

The COVID-19 pandemic created significant challenges on the operative elective surgeries as curbing coronavirus outbreak was prioritized over the surgeries that were not life-threatening unlike COVID. Therefore, a huge decline in the elective procedures, operative dental procedures, orthopedic surgeries as well as emergency room visits in the hospitals and operation theatres were on a hold for a significant amount of period that caused an immense downfall in terms of number of post-operative surgeries during the pandemic period, impeding the rise of bone growth stimulators market growth. Due to lack of industrial operations and a halt in commercial campaigns, implementation of government policies, investments in projects and other initiatives due to covid pandemic., which lead a decline in the self-healing materials market expansion. The COVID-19 pandemic disrupted demand patterns, significantly impacting the bone growth stimulators market.

The bone-related issues are prevalence day by day promoting bone growth stimulators market growth. Risin old age population is creating a want for bone treatment and surgeries propelling market growth. Growing rates of bone-related illnesses have been driving market growth. One of the major causes of utilization use of such stimulators is the rising incidence of bone illnesses across the globe. Osteoporosis is one of the major cause augmenting market expansions. The requirement for these stimulators to promote quick healing has been fueled by the rising incidence of bone fractures due to osteoporosis.

Growing patient preference towards non-invasive bone growth stimulators is promoting market growth. Increasing prevalence and acceptance for non-invasive procedures is gaining consumers attention during coarse of time. The most recent development over the past few years has been a rise in the acceptance and preference for non-Consequently, the market has grown as a result of the rising incidence of these injuries and orthopedic procedures. Throughout the course of the treatment, the device is placed over the fracture site for a certain amount of time.

Comprehensive Analysis of Bone Growth Stimulators Market

The bone growth stimulators market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by product, by application and by end users. The product segmentation includes, Bone Growth Stimulation Devices [Electrical Bone Growth Stimulators {Capacitive Coupling Devices, Combined Magnetic Field Devices}, Implantable Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators], Bone Morphogenetic Proteins, & Platelet-Derived Growth Factor); By Application segmentation includes Spinal Fusion, Maxillofacial & Dental. However, the end users segmentation includes Hospitals & ASCs, Speciality Clinics.

The North America region lead the bone growth stimulators market by benefitting a market size of USD 0.83 billion in 2023 due to Rising medical costs, rising prevalence, and rising rates of related bone illnesses that call for the use of bone growth stimulators.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Orthofix Medical Inc. (U.S.), Zimmer Biomet (U.S.), Bioventus (U.S.), Medtronic (Ireland), DJO, LLC (U.S), Arthrex, Inc. (U.S.), Terumo Corporation (Japan) these market players provide a level-playing competitive landscape.

In December 2023, one of the recent research projects supporting the safety and effectiveness of PEMF stimulation in lumbar spine fusion procedures which are recommended for patients at verge of pseudoarthrosis was launched by Orthofix Medical Inc.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 5.0% from 2024-2032

Unit Value (USD Billion)

Segmentation By Product

Bone Growth Stimulation Devices
Electrical Bone Growth Stimulators
Capacitive Coupling (CC) Devices
Combined Magnetic Field Devices (CMF)
Pulsed Electromagnetic Field Devices (PEMF)
Implantable Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Bone Morphogenetic Proteins (BMP)
Platelet-Derived Growth Factor (PDGF)

By Application

Spinal Fusion
Maxillofacial & Dental
Nonunion and Union Bone Fractures
Others

By End-user

Hospitals & ASCs
Speciality Clinics
Home Care
Others

By Geography

North America (By Product, By Application, By End-user, and By Country)
U.S. (By Application)
Canada (By Application)
Europe (By Product, By Application, By End-user, and By Country)
U.K. (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Product, By Application, By End-user, and By Country)
China (By Application)
Japan (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Product, By Application, By End-user, and By Country)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa (By Product, By Application, By End-user, and By Country)
GCC (By Application)
South Africa (By Application)
Rest of Middle East & Africa (By Application)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Bone Diseases, By Key Country, 2022/2023; 4.2. Technology Advances in Bone Growth Stimulator; 4.3. New product launches; 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships); 4.5. Impact of COVID-19 on the Market
5. Global Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. Bone Growth Stimulation Devices; 5.1.1.1. Electrical Bone Growth Stimulator; 5.1.1.1.1. Capacitive Coupling (CC) Devices; 5.1.1.1.2. Combined Magnetic Field Devices (CMF); 5.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 5.1.1.2. Implantable Bone Growth Stimulator; 5.1.1.3. Ultrasonic Bone Growth Stimulator; 5.1.2. Bone Morphogenetic Proteins (BMP); 5.1.3. Platelet-Derived Growth Factor (PDGF); 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Spinal Fusion; 5.2.2. Maxillofacial & Dental; 5.2.3. Nonunion and Union Bone Fractures; 5.2.4. Others; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Hospitals & ASCs; 5.3.2. Speciality Clinics; 5.3.3. Home Care; 5.3.4. Others; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East Africa
6. North America Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. Bone Growth Stimulation Devices; 6.1.1.1. Electrical Bone Growth Stimulator; 6.1.1.1.1. Capacitive Coupling (CC) Devices; 6.1.1.1.2. Combined Magnetic Field Devices (CMF); 6.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 6.1.1.2. Implantable Bone Growth Stimulator; 6.1.1.3. Ultrasonic Bone Growth Stimulator; 6.1.2. Bone Morphogenetic Proteins (BMP); 6.1.3. Platelet-Derived Growth Factor (PDGF); 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Spinal Fusion; 6.2.2. Maxillofacial & Dental; 6.2.3. Nonunion and Union Bone Fractures; 6.2.4. Others; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospitals & ASCs; 6.3.2. Speciality Clinics; 6.3.3. Home Care; 6.3.4. Others; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.1.1. By Application; 6.4.2. Canada; 6.4.2.1. By Application
7. Europe Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. Bone Growth Stimulation Devices; 7.1.1.1. Electrical Bone Growth Stimulator; 7.1.1.1.1. Capacitive Coupling (CC) Devices; 7.1.1.1.2. Combined Magnetic Field Devices (CMF); 7.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 7.1.1.2. Implantable Bone Growth Stimulator; 7.1.1.3. Ultrasonic Bone Growth Stimulator; 7.1.2. Bone Morphogenetic Proteins (BMP); 7.1.3. Platelet-Derived Growth Factor (PDGF); 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Spinal Fusion; 7.2.2. Maxillofacial & Dental; 7.2.3. Nonunion and Union Bone Fractures; 7.2.4. Others; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Hospitals & ASCs; 7.3.2. Speciality Clinics; 7.3.3. Home Care; 7.3.4. Others; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. U.K.; 7.4.1.1. By Application; 7.4.2. Germany; 7.4.2.1. By Application; 7.4.3. France; 7.4.3.1. By Application; 7.4.4. Italy; 7.4.4.1. By Application; 7.4.5. Spain; 7.4.5.1. By Application; 7.4.6. Scandinavia; 7.4.6.1. By Application; 7.4.7. Rest of Europe; 7.4.7.1. By Application
8. Asia Pacific Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. Bone Growth Stimulation Devices; 8.1.1.1. Electrical Bone Growth Stimulator; 8.1.1.1.1. Capacitive Coupling (CC) Devices; 8.1.1.1.2. Combined Magnetic Field Devices (CMF); 8.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 8.1.1.2. Implantable Bone Growth Stimulator; 8.1.1.3. Ultrasonic Bone Growth Stimulator; 8.1.2. Bone Morphogenetic Proteins (BMP); 8.1.3. Platelet-Derived Growth Factor (PDGF); 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Spinal Fusion; 8.2.2. Maxillofacial & Dental; 8.2.3. Nonunion and Union Bone Fractures; 8.2.4. Others; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospitals & ASCs; 8.3.2. Speciality Clinics; 8.3.3. Home Care; 8.3.4. Others; 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 8.4.1. Japan; 8.4.1.1. By Application; 8.4.2. China; 8.4.2.1. By Application; 8.4.3. India; 8.4.3.1. By Application; 8.4.4. Australia; 8.4.4.1. By Application; 8.4.5. Southeast Asia; 8.4.5.1. By Application; 8.4.6. Rest of Asia Pacific; 8.4.6.1. By Application
9. Latin America Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. Bone Growth Stimulation Devices; 9.1.1.1. Electrical Bone Growth Stimulator; 9.1.1.1.1. Capacitive Coupling (CC) Devices; 9.1.1.1.2. Combined Magnetic Field Devices (CMF); 9.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 9.1.1.2. Implantable Bone Growth Stimulator; 9.1.1.3. Ultrasonic Bone Growth Stimulator; 9.1.2. Bone Morphogenetic Proteins (BMP); 9.1.3. Platelet-Derived Growth Factor (PDGF); 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Spinal Fusion; 9.2.2. Maxillofacial & Dental; 9.2.3. Nonunion and Union Bone Fractures; 9.2.4. Others; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Hospitals & ASCs; 9.3.2. Speciality Clinics; 9.3.3. Home Care; 9.3.4. Others; 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 9.4.1. Brazil; 9.4.1.1. By Application; 9.4.2. Mexico; 9.4.2.1. By Application; 9.4.3. Rest of Latin America; 9.4.3.1. By Application
10. Middle East & Africa Bone Growth Stimulator Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. Bone Growth Stimulation Devices; 10.1.1.1. Electrical Bone Growth Stimulator; 10.1.1.1.1. Capacitive Coupling (CC) Devices; 10.1.1.1.2. Combined Magnetic Field Devices (CMF); 10.1.1.1.3. Pulsed Electromagnetic Field Devices (PEMF); 10.1.1.2. Implantable Bone Growth Stimulator; 10.1.1.3. Ultrasonic Bone Growth Stimulator; 10.1.2. Bone Morphogenetic Proteins (BMP); 10.1.3. Platelet-Derived Growth Factor (PDGF); 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Spinal Fusion; 10.2.2. Maxillofacial & Dental; 10.2.3. Nonunion and Union Bone Fractures; 10.2.4. Others; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospitals & ASCs; 10.3.2. Speciality Clinics; 10.3.3. Home Care; 10.3.4. Others; 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region; 10.4.1. South Africa; 10.4.1.1. By Application; 10.4.2. GCC; 10.4.2.1. By Application; 10.4.3. Rest of Middle East & Africa; 10.4.3.1. By Application
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Orthofix Medical Inc.; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. Zimmer Biomet; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Bioventus; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Medtronic; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. DJO, LLC; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Arthrex, Inc.; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. Terumo Corporation; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 12.